TIM-3 Suppresses Anti-CD3/CD28-Induced TCR Activation and IL-2 Expression through the NFAT Signaling Pathway.

Area of Science:

• Immunology
• Molecular Biology

Background:

• T cell immunoglobulin and mucin-domain containing protein 3 (TIM-3) is expressed on Th1 cells and acts as a negative regulator of T cell function.
• The intracellular tail of TIM-3, particularly residues Y265/Y272, is crucial for its inhibitory function, despite lacking canonical inhibitory motifs.
• TIM-3's interaction with kinases like ITK, Fyn, Lck, and PI3K suggests complex roles in regulating T cell signaling pathways, including IL-2 production via NF-κB/NFAT.

Purpose of the Study:

• To investigate the precise role of TIM-3 in T cell receptor (TCR)-mediated activation and signaling.
• To elucidate the molecular mechanisms by which TIM-3 negatively regulates T cell function.
• To validate findings in both engineered cell lines and primary human T cells.

Main Methods:

• Generated Jurkat T cell lines expressing human TIM-3 or chimeric constructs to study TCR-mediated activation, cytokine secretion, and protein interactions.
• Utilized a primary human CD8+ T cell system to examine endogenous TIM-3 function upon TCR ligation.
• Analyzed NF-κB/NFAT activation, CD69 expression, IL-2 secretion, and protein kinase associations (Lck, PLC-γ).

Main Results:

• In Jurkat cells, TIM-3 expression inhibited TCR-mediated NF-κB/NFAT activation, CD69 expression, and IL-2 secretion.
• Primary human CD8+ T cells expressing endogenous TIM-3 showed reduced NFAT reporter activity and IL-2 secretion upon TCR stimulation.
• TIM-3 was found to associate with Src kinase Lck and PLC-γ in primary CD8+ T cells.

Conclusions:

• TIM-3 functions as a negative regulator of TCR signaling.
• TIM-3 attenuates T cell activation signals initiated by CD3/CD28 co-stimulation.
• These findings clarify TIM-3's role in immune response modulation and T cell exhaustion.